Pretty sure I recall Dr Rowe saying a 50% slowing in disease progression equates to a four-fold extension of life expectancy, which is a little bit mind blowing. It'd be interesting to see what would happen if the medication was stopped, when rapamycin was ceased after a month in the Ike the mouse study the benefits continued. Although, if I were a trial participant I'd be about as open to stopping as I would be to dancing bare arsed in a bum rape factory.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-885
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 34651 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 78289 | 2 |
View Market Depth
| Last trade - 09.23am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
0.000 ( 0.47 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 21.5¢ | 21.0¢ | 137191 | ||
| Last updated 10.16am 04/06/2024 ? | |||||
| PAA (ASX) Chart |
Day chart unavailable